Fairfield Bush & CO. raised its position in shares of MetLife, Inc. (NYSE:MET) by 1.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,150 shares of the financial services provider’s stock after acquiring an additional 100 shares during the period. Fairfield Bush & CO.’s holdings in MetLife were worth $338,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Westside Investment Management Inc. grew its position in MetLife by 583.8% during the first quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock valued at $140,000 after acquiring an additional 2,300 shares during the period. Parallel Advisors LLC grew its position in MetLife by 50.7% during the first quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock valued at $143,000 after acquiring an additional 924 shares during the period. First Mercantile Trust Co. grew its position in MetLife by 3.4% during the second quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock valued at $161,000 after acquiring an additional 97 shares during the period. Carroll Financial Associates Inc. grew its position in MetLife by 5.8% during the second quarter. Carroll Financial Associates Inc. now owns 3,013 shares of the financial services provider’s stock valued at $165,000 after acquiring an additional 166 shares during the period. Finally, Rational Advisors LLC grew its position in MetLife by 14.3% during the first quarter. Rational Advisors LLC now owns 3,325 shares of the financial services provider’s stock valued at $176,000 after acquiring an additional 415 shares during the period. 74.25% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/10/11/fairfield-bush-co-boosts-holdings-in-metlife-inc-met.html.

Shares of MetLife, Inc. (MET) traded down 0.51% on Wednesday, hitting $52.87. The company’s stock had a trading volume of 1,163,214 shares. The stock has a market capitalization of $56.10 billion, a P/E ratio of 40.36 and a beta of 1.47. MetLife, Inc. has a 52 week low of $40.53 and a 52 week high of $53.30. The stock’s 50 day moving average price is $49.50 and its 200 day moving average price is $47.78.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.83 earnings per share. On average, analysts forecast that MetLife, Inc. will post $4.62 earnings per share for the current fiscal year.

A number of research firms have issued reports on MET. FBR & Co downgraded MetLife from a “buy” rating to a “neutral” rating and lowered their price target for the company from $53.00 to $52.00 in a research report on Tuesday. ValuEngine downgraded MetLife from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Zacks Investment Research raised MetLife from a “strong sell” rating to a “hold” rating in a research report on Monday. TheStreet raised MetLife from a “c+” rating to a “b” rating in a research report on Wednesday, October 4th. Finally, Morgan Stanley boosted their price target on MetLife from $54.00 to $55.00 and gave the company an “equal weight” rating in a research report on Thursday, October 5th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company. MetLife has a consensus rating of “Hold” and a consensus price target of $57.38.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.